Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibody response to COVID-19 vaccination in patients with lymphoma.
Narita K, Nakaji S, Tabata R, Terao T, Kuzume A, Tsushima T, Ikeda D, Fukumoto A, Miura D, Takeuchi M, Doi M, Umezawa Y, Otsuka Y, Takamatsu H, Matsue K. Narita K, et al. Among authors: otsuka y. Int J Hematol. 2022 May;115(5):728-736. doi: 10.1007/s12185-022-03305-z. Epub 2022 Feb 21. Int J Hematol. 2022. PMID: 35188650 Free PMC article.
Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study.
Narita K, Ikeda D, Seki M, Fukumoto A, Tabata R, Uesugi Y, Miura D, Takeuchi M, Doi M, Umezawa Y, Otsuka Y, Matsue K. Narita K, et al. Among authors: otsuka y. Hemasphere. 2023 Jun 6;7(6):e905. doi: 10.1097/HS9.0000000000000905. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37292116 Free PMC article. No abstract available.
Immunogenicity of simultaneous versus sequential administration of a 23-valent pneumococcal polysaccharide vaccine and a quadrivalent influenza vaccine in older individuals: A randomized, open-label, non-inferiority trial.
Nakashima K, Aoshima M, Ohfuji S, Yamawaki S, Nemoto M, Hasegawa S, Noma S, Misawa M, Hosokawa N, Yaegashi M, Otsuka Y. Nakashima K, et al. Among authors: otsuka y. Hum Vaccin Immunother. 2018;14(8):1923-1930. doi: 10.1080/21645515.2018.1455476. Epub 2018 May 14. Hum Vaccin Immunother. 2018. PMID: 29561248 Free PMC article. Clinical Trial.
Immunogenicity and safety of COVID-19 vaccine in lung cancer patients receiving anticancer treatment: A prospective multicenter cohort study.
Nakashima K, Ishida M, Matsui H, Yoshida C, Nagai T, Shiraga M, Nakaoka H, Otsuka Y, Nakagama Y, Kaku N, Nitahara Y, Kido Y, Hirota Y. Nakashima K, et al. Among authors: otsuka y. Hum Vaccin Immunother. 2022 Nov 30;18(6):2140549. doi: 10.1080/21645515.2022.2140549. Epub 2022 Nov 11. Hum Vaccin Immunother. 2022. PMID: 36369871 Free PMC article.
1,593 results